[An analysis of the importance of low-molecular peptides in regulating human motor functions in diseases of the central nervous system].
The clinical data obtained on the treatment of motor disorders with intrathecal administration of low-molecular peptides, suggest that the peptides are effective in Parkinsonian disease, extrapyramidal hyperkineses and in spinal cord disturbances.